Florida Cancer Specialists & Research Institute will showcase 10 clinical research abstracts at the upcoming ESMO Congress 2026, underscoring its active role in early-phase oncology drug development.
Florida Cancer Specialists & Research Institute announced its drug development research will be featured at ESMO Congress 2026, but no direct financial impact is indicated.
Florida Cancer Specialists & Research Institute announced that 10 of its clinical research abstracts have been selected for presentation at the ESMO Congress 2026. The research highlights the organization's ongoing contributions to early-phase oncology drug development.
The presentation of 10 abstracts highlights the organization's active participation and contribution to global oncology clinical trials and drug development.